InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by PAUL STEVEN M, Chairman & CEO. Officer active across 3 companies, notably Karuna Therapeutics, Inc.. Cumulatively, 5 filings have been published. Total volume traded: €213k. The latest transaction was disclosed on 1 April 2022 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations5 total
€153,49015,000 shares@ €10.23270.0004% mcap100.0% of flow
Common Stock
SEC:0001735276-22-000039:0·
€371 shares@ €37.4067100.0% of flow
Common Stock
SEC:0001562180-21-007019·
€371 shares@ €37.406750.0% of flow
Common Stock
SEC:0001562180-21-007019:0·
€106,7151,183 shares@ €90.207100.0% of flow
Common Stock
SEC:0001593968-21-001992·
Ideal exit: 14 May 2022 (T+270)
€106,7151,183 shares@ €90.20750.0% of flow
Common Stock
SEC:0001593968-21-001992:0·
Ideal exit: 14 May 2022 (T+270)
5 of 5 declarations
About PAUL STEVEN M
Mr. Paul Steven M. is Chairman & CEO and Board Member of Karuna Therapeutics, Inc., Sage Therapeutics, Inc., and ALNYLAM PHARMACEUTICALS, INC. He leads the operations and strategy of these companies, bringing his expertise in the pharmaceutical sector.
